HitGen Past Earnings Performance
Past criteria checks 4/6
HitGen's earnings have been declining at an average annual rate of -22.9%, while the Life Sciences industry saw earnings growing at 21.5% annually. Revenues have been growing at an average rate of 9.1% per year. HitGen's return on equity is 4.8%, and it has net margins of 16.4%.
Key information
-22.9%
Earnings growth rate
-25.7%
EPS growth rate
| Life Sciences Industry Growth | 26.8% |
| Revenue growth rate | 9.1% |
| Return on equity | 4.8% |
| Net Margin | 16.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How HitGen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 409 | 67 | -1 | -8 |
| 31 Dec 23 | 372 | 44 | 0 | 0 |
| 30 Sep 23 | 357 | 33 | 91 | 82 |
| 30 Jun 23 | 347 | 38 | 92 | 84 |
| 31 Mar 23 | 327 | 23 | 89 | 91 |
| 31 Dec 22 | 330 | 25 | 92 | 87 |
| 30 Sep 22 | 302 | 44 | 88 | 86 |
| 30 Jun 22 | 296 | 36 | 85 | 83 |
| 31 Mar 22 | 314 | 51 | 84 | 76 |
| 31 Dec 21 | 311 | 63 | 77 | 74 |
| 30 Sep 21 | 345 | 79 | 80 | 75 |
| 30 Jun 21 | 311 | 69 | 69 | 87 |
| 31 Mar 21 | 269 | 61 | 61 | 90 |
| 31 Dec 20 | 244 | 64 | 52 | 98 |
| 30 Sep 20 | 235 | 61 | 53 | 104 |
| 30 Jun 20 | 244 | 76 | 53 | 97 |
| 31 Mar 20 | 258 | 85 | 59 | 91 |
| 31 Dec 19 | 264 | 120 | 59 | 87 |
| 31 Dec 18 | 151 | 45 | 37 | 58 |
| 31 Dec 17 | 53 | -23 | 31 | 45 |
Quality Earnings: 688222 has high quality earnings.
Growing Profit Margin: 688222's current net profit margins (16.4%) are higher than last year (7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688222's earnings have declined by 22.9% per year over the past 5 years.
Accelerating Growth: 688222's earnings growth over the past year (193%) exceeds its 5-year average (-22.9% per year).
Earnings vs Industry: 688222 earnings growth over the past year (193%) exceeded the Life Sciences industry 0.9%.
Return on Equity
High ROE: 688222's Return on Equity (4.8%) is considered low.